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In-cell enzymatic glycosylation
A way to improve productivity of heterologous 
biosynthesis pathways in micro-organisms
Biarritz June 7th 2012
Disclaimer
The shares of Evolva Holding (“Evolva”) are traded on the SIX Swiss 
Stock Exchange (ticker: “EVE”).
This presentation may contain specific forward
relating to Evolva's future business, development and economic 
performance.  e.g., statements including terms like "believe", 
"assume", "expect" or similar expressions. Such forward
statements are subject to known and unknown risks, uncertainties 
and other factors which may result in a substantial divergence 
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between the actual results, financial situation, development or 
performance of Evolva and those explicitly or implicitly presumed in 
these statements. 
Against the background of these uncertainties readers should not rely 
on forward-looking statements. 
Evolva assumes no responsibility to update forward






 Unique, proven, widely applicable, biosynthesis technology
□ Creates novel products and production methods in yeast
□ More than 50 patent families filed to date
 Product focus in 3 ”health & wellness” areas
□ Natural flavorants and sweeteners:  Vanilla, Stevia
□ Protection against microbial pathogens:  Pomecins
□ Diabetes & obesity:  EV-077, Stevia
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 B2B model focused on core competencies
□ Provide innovative ingredients to other companies
□ Partnerships with Roche, IFF, BASF, Roquette, US DoD
□ 2010 revenues CHF 18.6 mn (1H 2011 CHF 6.9mn)
 Many pharma & food majors want to grow in space
□ But have limited partnering or acquisition options 







Vanilla 2014 $   0.4 bn
Slid
and a highly experienced team
Pomecin 2015 $   2 bn
Stevia 2015 $   4 bn
EV-077 2017 $ 10 bn
This Presentation
 Glycosylation and the effects of glycosylation
 Glycosyltransferases
 Examples
□ Vanillin biosynthesis in yeast
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□ Saffron biosynthesis in yeast












 A glycoside is a molecule in which a sugar group is bonded 
through its anomeric carbon to another carbon group via 
O-glycosidic, S-glycosidic, or N-glycosidic
 “Small molecule” glycosides play important roles in especially 
micro-organisms and plants, e.g. in defence
□ Some toxic defence compounds are stored as non
□ E.g. dhurrin, vanillin-glucoside and glucosinolates
 In animals, small compound glycosylation is used as a mean 
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for detoxifying and excreting unwanted lipophilic compounds 
□ Glycosylation is performed by promiscuous 
the liver
□ Water solubility is increased, facilitating excretion via the 
 Typical effects of glycosylating a scaffold
□ Decreases the compound’s cellular toxicity 
□ Increases the compound’s aqueous solubility
□ Increases the compound’s biosynthesis rate and 






Aglycon is unstable and 







Hydrolyzed by myrosinases upon
tissue damage, resulting in 
release of biologically active 
compounds
Glycosylation Increases Solubility of 
Increased solubility: Insoluble curcumin gains 
solubility by glucosylation (Kaminaga et al.)
Solubility increase





















Ref.: Kaminaga et al. (2003) FEBS Lett. 555: 311
Use: 
Several experimental (cancer, 
anti-inflammation, etc.)




Production microorganism dies when high 






Production microorganism survives when 












Family 1 Glycosyltransferases –
 A GT is an enzyme that can transfer a sugar from one molecule to 
 Family 1 UDP-glycosyltransferases (UGTs)
□ 1 out of 91 GT families – a large family present in both animals, plants and microorganisms
□ Small hydrophobic molecules as natural substrates
□ Involved in synthesis of many different secondary plant metabolites: 
compounds, flavour and more
□ Involved in detoxification of xenobiotic compounds
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□ Use uridine diphosphate-activated sugars as sugar 






















































Rooted phylogenetic tree – Arabidopsis thaliana 
Most uses UDP-glucose as sugar donor
Many plant UGTs have shown to be very 
promiscuous towards acceptor substrate
Arabidopsis thaliana contains 122 different 
UGTs
70% of 87 small molecule drugs were 






































































































The Process of Making an In Cell Glycosylation 
 1. Prerequisites:
□ Product needs to have a suitable hydroxy
glycosylated
□ The added sugar moiety is to some extent “wasted” 
to be a high or medium priced product
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for a Biosynthetic Process
, thio or amino group that can be 










The Process of Making an In Cell Glycosylation 
 1. Prerequisites:
□ Product needs to have a suitable hydroxy
glycosylated
□ The added sugar moiety is to some extent “wasted” 
to be a high or medium priced product
 2. Finding a suitable glycosyltransferase
desired glycosylation
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for a Biosynthetic Process
, thio or amino group that can be 
– product therefore needs 


































detected by HPLC or HPLC-MS
 1. Prerequisites:
□ Product needs to have a suitable hydroxy
glycosylated
□ The added sugar moiety is to some extent “wasted” 
to be a high or medium priced product
 2. Finding a suitable glycosyltransferase
desired glycosylation
The Process of Making an In Cell G
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 3. Testing the glycosylation in the desired 
, thio or amino group that can be 
– product therefore needs 
that can perform the 




























 An example showing varying glycosylation of heterologous 
pathway intermediates and end product 
□ Though a number of UGTs are found to do the reaction 
perform quite differently in vivo
0
500
UGT1 UGT2 UGT3 UGT4 UGT5 UGT6
Desired In Vivo System
Slide
in vivo
in vitro they may 
UGT7 UGT8 UGT9 UGT10 UGT11 UGT12
 1. Prerequisites:
□ Product needs to have a suitable hydroxy, 
□ The added sugar moiety is to some extent “wasted”. Product therefore 
high or medium priced product
□ Not suitable for biofuel production
 2. Finding a suitable glycosyltransferase
glycosylation
The Process of Making an In Cell Glycosylation 
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 3. Testing the glycosylation in the desired in vivo 
 4. Find a suitable method for deglycosylation
product (if necessary)










thio or amino group that can be glycosylated
needs to be a 
that can perform the desired 





































































 De-novo vanillin pathway 
assembled in Saccharomyces 
cerevisisae from genes of 
fungal, mammal and bacterial 
origin




production of vanillin is the 
toxicity
□ Negatively affects  growth of 
Saccharomyces cerevisiae even 
at 0.5 g/L
(Hansen et al., 2009 AEM)





























































(Hansen et al., 2009 AEM)



























 Glycosylation of vanillin solves toxicity issue
□ Vanillin toxic even at 0.5 
□ Vanillin glucoside non-toxic even at 25 
□ Thus VG is at least 50 times less toxic than vanillin














































Solubility of Vanillin vs. Vanillin 
 Water solubility of vanillin and VG depends on ionization, 
pH and temperature and different values have been 
reported
 Predicted solubility of vanillin glucoside
mM (110.5 g/L)
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□ Our experiments showed 114 mM
 Predicted solubility of vanillin is 45 
□ Our experiments showed 41mM
 Gain in solubility thus in the 2-8 fold range
Glucoside































































 Vanillin glucoside is readily 
excreted from the cell
□ The glycosylation step removes the 
vanillin and thereby helps to create 
sink conditions that provides extra 
“pull” in the pathway
Slide
□ Concentration ratio 
Intracellular:extracellular is approx. 
1:5, which indicates that active 
excretion is involved
Purification of Vanillin via Deglucosylation
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 Vanillin glucoside produced in yeast gets 




glucoside means vanillin can be purified 
Towards Getting Fermentation 
 The use of glycosylation technology has allowed for a high vanillin 
glucoside titer
□ Production cost is now at a level where fermentation derived vanillin is 
competitive in certain markets
 2011 targets for vanilla programme was achieved
□ Scale-up scheduled to be initiated early 2013
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 The characteristic saffron flavour, colour and odour come 
from several components
□ Most important are picrocrocin, crocin and safranal
the crocus stigma
 The colour of saffron is primarily the result of 
(trans-crocetin di-(β-D-gentiobiosyl) ester)
 Principal aroma constituent is safranal, which is released 
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from picrocrocin
 Purpose of the project is to produce the key compounds 
picrocrocin and crocin in yeast via fermentation
□ Crocin is a tetra glucosylated crocetin molecule
□ Picrocrocin is a mono glucoside
Crocetin (The aglycon of crocin)





 The end products are glycosides themselves
 Advantages of producing a glycoside still applies
□ Solubility: Crocin is water soluble, while 
Crocetin
Sparingly soluble in water 
(Merck index)
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 Main advantages of producing key 
□ Allows “saffron” to be available at a much 
existing markets and open new ones
□ Eliminate the many complexities involved in the current supply 
□ By making each of the key components separately it will enable the production of 
customised forms that are for exam
that can be adapted to specific food formulations and regional 
crocetin is almost insoluble
Crocin
Freely soluble in hot water 
(Merck index)
Slide
saffron components by fermentation:
decreased price, which will both expand 
chain








































 Steviol glycosides originating from the plant 
widely used as natural high intensity sweeteners
 Functional pathway established in bakers yeast 
 Taste pattern of the stevia glycosides is 





□ Difference in sweetness, bitterness and liqurice 
aftertaste
in Yeast
Stevia rebaudiana are 
(Sacchromyces cerevisiae)
Slide






 Naturally occuring 
glycosylation pathway in 
Stevia rebaudiana
 Glycosylation pathway 
functional in yeast















□ 5-7 steps to prenyl 
phosphates
□ Steviol pathway
□ 5 steps to steviol
□ Glycosylation pathway
















































































































 Production by fermentation allows pure Stevia 
sweetener components to be produced
□ Several of the most attractive Stevia components are present 
at very low concentrations in the plant and 
extract
□ Glycosylation platform allows for production of specific 
steviosides/rebaudiosides by selection and use of 
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specific UGTs




detected by HPLC or HPLC-MS
Conclusions
 Glycosylation is a very valuable tool 
heterologous biosynthesis pathways in 
□ Main benefits are:
□ Improved solubility
□ Decreased toxicity
□ Improved “sink” conditions in pathway
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 Several high value products are glycosides
□ Exact glycosylation patterns crucial for product profile











+45 35 200 235
+45 26 87 24 05
